Beranda › Kondisi Pasca-COVID (Long COVID) › Texas › Dallas
Uji klinis Kondisi Pasca-COVID (Long COVID) di Dallas, TX
5 studi untuk Kondisi Pasca-COVID (Long COVID) mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Menerima pesertaFase 3
- Research Site, Dallas
A Study of COVID-19 Vaccine(s) in Children and Adults
Menerima pesertaFase 3Sukarelawan sehat diterima
- Cedar Health Research, Dallas
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Menerima pesertaFase 3
- Zenos Clinical Research, Dallas
- Baylor Scott & White Health - Center for Advanced Heart and Lung Disease, Dallas
- Baylor Scott & White Research Institute - Clinical Trials Office, Dallas
- dan 1 lainnya
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
Menerima pesertaFase 3
- Zenos Clinical Research, Dallas
- Southwest Family Medicine Associates, Dallas
- Southwest Mind and Body Care, Dallas
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Menerima pesertaFase 3
- UT Southwestern Medical Center, Dallas
Uji klinis Kondisi Pasca-COVID (Long COVID) di kota lain
- New York City, NY15 studi
- Houston, TX13 studi
- Boston, MA13 studi
- Baltimore, MD12 studi
- Chicago, IL11 studi
- Washington, DC10 studi
- San Francisco, CA8 studi
- Durham, NC8 studi
- Atlanta, GA8 studi
- San Diego, CA7 studi
- Los Angeles, CA6 studi
- Pittsburgh, PA6 studi
Studi lain di Dallas
- Kanker Payudara55 studi
- Kanker Paru Non-Sel Kecil52 studi
- Kanker Metastatik42 studi
- Gagal Jantung42 studi
- Kanker (semua jenis)37 studi
- Kanker Prostat36 studi
- Kanker Kolorektal33 studi
- Obesitas30 studi
- Kanker Ovarium28 studi
- Kanker Paru27 studi
- Kanker Kandung Kemih27 studi
- Kanker Endometrium24 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.